Neurocrine Biosciences Inc vs Sibanye Stillwater Ltd — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Sibanye Stillwater Ltd trades at $8.59 (market cap $5.66B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.1× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays a 3.89% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | SBSW | |
|---|---|---|
Market Cap | $17.40B | $5.66B |
Sector | Health | Basic Materials |
52-Week High | $180.55 | $21.12 |
52-Week Low | $123.10 | $7.27 |
Enterprise Value | $16.49B | $7.28B |
Dividend Yield | — | 3.89% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →